-
Product Insights
NewEctonucleoside Triphosphate Diphosphohydrolase 1 – Drugs In Development, 2024
The Ectonucleoside Triphosphate Diphosphohydrolase 1 pipeline drugs market research report outlays comprehensive information on the Ectonucleoside Triphosphate Diphosphohydrolase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, and Cardiovascular which include indications of Solid Tumor, Unspecified Cancer, Autoimmune Disorders, Inflammation, Coronary Artery Disease (CAD) (Ischemic Heart Disease), and Stroke. It also reviews key players involved...
-
Product Insights
NewSialic Acid Binding Immunoglobulin Type Lectin – Drugs In Development, 2024
The Sialic Acid Binding Immunoglobulin Type Lectin pipeline drugs market research report outlays comprehensive information on the Sialic Acid Binding Immunoglobulin Type Lectin targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Immunology, and Ophthalmology which include indications of B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia), Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia),...
-
Product Insights
NewMacrophage Migration Inhibitory Factor – Drugs In Development, 2024
The Macrophage Migration Inhibitory Factor pipeline drugs market research report outlays comprehensive information on the Macrophage Migration Inhibitory Factor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Central Nervous System, and Respiratory which include indications of Oncology, Unspecified Cancer, Rheumatoid Arthritis, Inflammation, Multiple Sclerosis, Alzheimer's Disease, Asthma, and Acute Respiratory Distress Syndrome. It also reviews...
-
Product Insights
NewMuscarinic Acetylcholine Receptor M4 – Drugs In Development, 2024
The Muscarinic Acetylcholine Receptor M4 pipeline drugs market research report outlays comprehensive information on the Muscarinic Acetylcholine Receptor M4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Genetic Disorders, Undisclosed, and Cardiovascular which include indications of Schizophrenia, Alzheimer's Disease, Fragile X Syndrome, Tuberous Sclerosis, Unspecified Rare Disease, and Systolic Hypertension. It also reviews key...
-
Product Insights
NewRetinoic Acid Receptor Gamma – Drugs In Development, 2024
The Retinoic Acid Receptor Gamma pipeline drugs market research report outlays comprehensive information on the Retinoic Acid Receptor Gamma targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Dermatology, Musculoskeletal Disorders, Respiratory, and Oncology which include indications of Acne Vulgaris, Hand Dermatitis, Musculoskeletal Disorders, Fibrosis, Bronchopulmonary Dysplasia, Idiopathic Pulmonary Fibrosis, Head And Neck Cancer, and Non-Small Cell Lung...
-
Product Insights
NewCarbonic Anhydrase – Drugs In Development, 2024
The Carbonic Anhydrase pipeline drugs market research report outlays comprehensive information on the Carbonic Anhydrase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Ophthalmology, and Metabolic Disorders which include indications of Oncology, Glioblastoma Multiforme (GBM), Epilepsy, Migraine, Ocular Hypertension, Open-Angle Glaucoma, and Obesity. It also reviews key players involved in Carbonic Anhydrase targeted...
-
Product Insights
NewC-X-C Chemokine Receptor Type 2 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 2 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Respiratory, and Metabolic Disorders which include indications of Solid Tumor, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Inflammation, Autoimmune Disorders, Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease...
-
Product Insights
NewIntegrin Beta 7 – Drugs In Development, 2024
The Integrin Beta 7 pipeline drugs market research report outlays comprehensive information on the Integrin Beta 7 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Immunology, and Infectious Disease which include indications of Inflammatory Bowel Disease, Ulcerative Colitis, Immunology, Unspecified Immunological Disorders, and Human Immunodeficiency Virus (HIV) Infections (AIDS). It also reviews key players involved in...
-
Product Insights
NewVoltage Dependent Calcium Channel Subunit Alpha2/Delta1 – Drugs In Development, 2024
The Voltage Dependent Calcium Channel Subunit Alpha2/Delta1 pipeline drugs market research report outlays comprehensive information on the Voltage Dependent Calcium Channel Subunit Alpha2/Delta1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Immunology, and Ophthalmology which include indications of Neuropathic Pain (Neuralgia), Diabetic Neuropathic Pain, Solid Tumor, Inflammation, and Glaucoma. It also reviews key...
-
Product Insights
New70S Ribosome – Drugs In Development, 2024
The 70S Ribosome pipeline drugs market research report outlays comprehensive information on the 70S Ribosome targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Respiratory, Central Nervous System, and Genito Urinary System which include indications of Bacterial Infections, Skin And Skin Structure Infections (SSSI) Caused By Bacteria, Cystic Fibrosis, Bronchiectasis, Primary Progressive Multiple Sclerosis (PPMS), Relapsing...